Growth Metrics

Zoetis (ZTS) Common Equity (2016 - 2025)

Zoetis (ZTS) has disclosed Common Equity for 13 consecutive years, with $5.4 billion as the latest value for Q3 2025.

  • On a quarterly basis, Common Equity rose 3.13% to $5.4 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $5.4 billion, a 3.13% increase, with the full-year FY2024 number at $4.8 billion, down 4.43% from a year prior.
  • Common Equity was $5.4 billion for Q3 2025 at Zoetis, up from $5.0 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $5.4 billion in Q3 2025 to a low of $4.1 billion in Q1 2021.
  • A 5-year average of $4.7 billion and a median of $4.7 billion in 2022 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: soared 48.64% in 2021, then decreased 7.86% in 2025.
  • Zoetis' Common Equity stood at $4.5 billion in 2021, then dropped by 3.1% to $4.4 billion in 2022, then rose by 13.35% to $5.0 billion in 2023, then decreased by 4.43% to $4.8 billion in 2024, then grew by 13.17% to $5.4 billion in 2025.
  • Per Business Quant, the three most recent readings for ZTS's Common Equity are $5.4 billion (Q3 2025), $5.0 billion (Q2 2025), and $4.7 billion (Q1 2025).